EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
2023 · Annals of the Rheumatic Diseases · 593 citations
https://doi.org/10.1136/ard-2022-223764
B
Bernhard Hellmich
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
580
Papers
14.2K
Citations
50
h-index
105
i10-index
Bernhard Hellmich is an academic researcher from University Children's Hospital Tübingen. The author has contributed to research in topics: Medical and Health Sciences Research & Vasculitis and related conditions & Medical Practices and Rehabilitation. The author has an h-index of 50, co-authored 493 publications.
ORCID: 0000-0002-8014-1801Papers by this author
worksRevised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis
2017 · Nature Reviews Rheumatology · 441 citations
https://doi.org/10.1038/nrrheum.2017.140
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
2021 · Arthritis & Rheumatology · 153 citations
https://doi.org/10.1002/art.41943
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study
2025 · Journal of Autoimmunity · 13 citations
https://doi.org/10.1016/j.jaut.2025.103398
Recommendations for defining giant cell arteritis fast-track clinics. English version
2024 · Zeitschrift für Rheumatologie · 10 citations
https://doi.org/10.1007/s00393-024-01532-9
Zukunft der akutstationären Rheumatologie in Deutschland
2020 · Zeitschrift für Rheumatologie · 6 citations
https://doi.org/10.1007/s00393-020-00939-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat